BiomX Inc. (PHGE)
CIK 1739174 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 10.1M shares as of May 20, 2026 (10-Q). Share count fell from 29.0M to 1.6M between Nov 11, 2025 and Feb 16, 2026, a pattern consistent with a reverse split (roughly 1-for-18); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Inducement Warrants | 366,087 | $17.68 | — | — |
| Common Warrants | 312,503 | $17.68 | — | — |
| Private Placement Warrants | 203,444 | $43.91 | — | — |
| AR Warrants | 157,603 | $0.0001 | — | — |
| January Two Thousand Twenty Six Private Placement Agent Warrants | 99,000 | $2.5 | — | — |
| Agents Warrants | 50,126 | $43.91 | — | — |
| Private Pre Funded Warrants | 46,232 | $0.0019 | — | — |
| Registered Pre Funded Warrants | 42,381 | $0.0019 | — | — |
| Two Thousand Twenty One Registered Direct Offering Warrants | 14,808 | $950 | — | — |
| Merger Warrants | 11,404 | $950 | — | — |
| Landlord Warrants | 1,316 | $950 | — | — |
| Warrant | 298 | $2 | 5y | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 20, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 21.9M underlying shares, as reported Sep 30, 2025 (10-Q).
Reported exercise price: $0.0001 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $1.7M as of Mar 31, 2026.
Rough fully diluted estimate: 32.1M = 10.1M O/S + 21.9M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed May 20, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 10.1M | May 20, 2026 |
| + Inducement Warrants (if exercised) | 366,087 | Mar 31, 2026 |
| + Common Warrants (if exercised) | 312,503 | Mar 31, 2026 |
| + Private Placement Warrants (if exercised) | 203,444 | Mar 31, 2026 |
| + AR Warrants (if exercised) | 157,603 | Mar 31, 2026 |
| + January Two Thousand Twenty Six Private Placement Agent Warrants (if exercised) | 99,000 | Mar 31, 2026 |
| + Agents Warrants (if exercised) | 50,126 | Mar 31, 2026 |
| + Private Pre Funded Warrants (if exercised) | 46,232 | Mar 31, 2026 |
| + Registered Pre Funded Warrants (if exercised) | 42,381 | Mar 31, 2026 |
| + Two Thousand Twenty One Registered Direct Offering Warrants (if exercised) | 14,808 | Mar 31, 2026 |
| + Merger Warrants (if exercised) | 11,404 | Mar 31, 2026 |
| + Landlord Warrants (if exercised) | 1,316 | Mar 31, 2026 |
| + Warrant (if exercised) | 298 | Nov 30, 2017 |
| Fully diluted estimate | 11.5M | +12.9% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $26.4Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 9 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full PHGE workspace